Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Guerrin

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1987
Influence of frusemide on cis-dichlorodiammineplatinum (II) pharmaco-kineticsM Dumas, P d'Athis, C de Gislain, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinumM Dumas, C de Gislain, P d'Athis, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Proton nuclear magnetic resonance spectroscopy of plasma lipoproteins in malignancyJ M Nabholtz, A Rossignol, M Farnier, et al.
Journal D'Urologie|January 1, 1989
[Prostatic tumors. Detection by proton nuclear magnetic resonance spectroscopy of plasma lipoproteins]J M Nabholtz, J C Tremeaux, A Rossignol, et al.
Revue Francaise De Gynecologie Et D'Obstetrique|November 1, 1970
[Primary nevocarcinoma of the cervix uteri]F Cabanne, R Michiels, M Gauliard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Influence of hydration on ultrafilterable platinum kinetics and kidney function in patients treated with cis-diamminedichloroplatinum(II)M Dumas, C de Gislain, P d'Athis, et al.
International Journal of Cancer|August 7, 1997
Loss of heterozygosity at the TP53 gene: independent occurrence from genetic instability events in node-negative breast cancerS Lizard-Nacol, J M Riedinger, G Lizard, et al.
Cancer Research|October 1, 1995
Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancyS Lizard-Nacol, R Lidereau, F Collin, et al.
Neuroscience and Biobehavioral Reviews|August 2, 2025
Precision medicine in substance use disorders: Integrating behavioral, environmental, and biological insightsCyprien G J Guerrin, Debbie R M Tesselaar, Jan Booij, et al.
Psychiatry Research|January 23, 2026
Metabolic brain connectivity analysis of a depressive-like phenotype in rats: a graph theory PET studyDaniel A Vazquez-Matias, Erik F J de Vries, Cyprien G J Guerrin, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1987
Influence of frusemide on cis-dichlorodiammineplatinum (II) pharmaco-kineticsM Dumas, P d'Athis, C de Gislain, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinumM Dumas, C de Gislain, P d'Athis, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Proton nuclear magnetic resonance spectroscopy of plasma lipoproteins in malignancyJ M Nabholtz, A Rossignol, M Farnier, et al.
Journal D'Urologie|January 1, 1989
[Prostatic tumors. Detection by proton nuclear magnetic resonance spectroscopy of plasma lipoproteins]J M Nabholtz, J C Tremeaux, A Rossignol, et al.
Revue Francaise De Gynecologie Et D'Obstetrique|November 1, 1970
[Primary nevocarcinoma of the cervix uteri]F Cabanne, R Michiels, M Gauliard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Influence of hydration on ultrafilterable platinum kinetics and kidney function in patients treated with cis-diamminedichloroplatinum(II)M Dumas, C de Gislain, P d'Athis, et al.
International Journal of Cancer|August 7, 1997
Loss of heterozygosity at the TP53 gene: independent occurrence from genetic instability events in node-negative breast cancerS Lizard-Nacol, J M Riedinger, G Lizard, et al.
Cancer Research|October 1, 1995
Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancyS Lizard-Nacol, R Lidereau, F Collin, et al.
Neuroscience and Biobehavioral Reviews|August 2, 2025
Precision medicine in substance use disorders: Integrating behavioral, environmental, and biological insightsCyprien G J Guerrin, Debbie R M Tesselaar, Jan Booij, et al.
Psychiatry Research|January 23, 2026
Metabolic brain connectivity analysis of a depressive-like phenotype in rats: a graph theory PET studyDaniel A Vazquez-Matias, Erik F J de Vries, Cyprien G J Guerrin, et al.
Pageof 7